Congresos

Título Añoorden ascendente
Novel allosteric inhibitors of the NS3 protease from the hepatitis C virus 2012
Bis(methyl)gliotoxin proves to be a stable and reliable biomarker for invasive aspergillosis and suitable for use in diagnosis. 2012
Bosonic Models with quantum circuits 2012
Cadmium impacts on soil bacterial activity through earthworm-mediated soil aggregation 2012
Activation of human allogeneic NK cells overcomes multidrug resistance in hematological tumors 2012
Therapeutic strategies for Gaucher disease: Miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase 2012
Modeling Administrative Procedures to Improve Information to the Public 2012
Solubility and stability enhancement of resveratrol and analogues: a comparative study between modified cyclodextrins and bile acids 2012
Experimental validation of in silico target predictions on synergistic protein targets 2012
Allogeneic activated NK cells overcomes drug-resistance in CLL 2012
Simulating Quantum Chirality with dissipation 2012
EUROPEAN NON-STATE (F)ACTORS AND THE ´ARAB SPRING´ - Assessing parliamentary inputs and media coverage(s) during the 2011 international military intervention in the Libyan conflict 2012
Structural screening of cupredoxins against malaria 2012
El mito del consentimiento o porque un sistema individualista de protección de datos (ya) no sirve para (casi) nada 2012
Bis(methyl)gliotoxin proves to be a stable and reliable biomarker for invasive aspergillosis and suitable for use in diagnosis 2012
Earthworm communities of Alpine grasslands affected by wild boar rooting and traditional livestock grazing changes in Central Pyrenees (Spain) 2012
Activated allogeneic NK cells use perforin and granzymes to overcome multidrug resistance in hematological tumors. 2012
Stem-cells and molecular imaging 2012
Stilbene active food packaging for the preservation of poultry meat 2012
Multiple CTL effector mechanisms involved in tumor rejection following CD137 mAb treatment 2012

Páginas